Company or ticker...

Editas Medicine

Editas develops gene-editing medicines using CRISPR technology.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

EDIT

400.1M

11.0

n/a

26.70%

Key Facts

M. Cap

PS

PE

YTD

400.1M

11.0

n/a

26.70%

10MA

20MA

50MA

200MA

$EDIT